Literature DB >> 25841626

The internal gene duplication and interrupted coding sequences in the MmpL genes of Mycobacterium tuberculosis: Towards understanding the multidrug transport in an evolutionary perspective.

Padmani Sandhu1, Yusuf Akhter2.   

Abstract

The multidrug resistance has emerged as a major problem in the treatment of many of the infectious diseases. Tuberculosis (TB) is one of such disease caused by Mycobacterium tuberculosis. There is short term chemotherapy to treat the infection, but the main hurdle is the development of the resistance to antibiotics. This resistance is primarily due to the impermeable mycolic acid rich cell wall of the bacteria and other factors such as efflux of antibiotics from the bacterial cell. The MmpL (Mycobacterial Membrane Protein Large) proteins of mycobacteria are involved in the lipid transport and antibiotic efflux as indicated by the preliminary reports. We present here, comprehensive comparative sequence and structural analysis, which revealed topological signatures shared by the MmpL proteins and RND (Resistance Nodulation Division) multidrug efflux transporters. This provides evidence in support of the notion that they belong to the extended RND permeases superfamily. In silico modelled tertiary structures are in homology with an integral membrane component present in all of the RND efflux pumps. We document internal gene duplication and gene splitting events happened in the MmpL genes, which further elucidate the molecular functions of these putative transporters in an evolutionary perspective.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Efflux pumps; MmpL genes; Multidrug resistance; Mycobacterium tuberculosis; RND transporters; Reductive evolution

Mesh:

Substances:

Year:  2015        PMID: 25841626     DOI: 10.1016/j.ijmm.2015.03.005

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  9 in total

Review 1.  A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.

Authors:  Aarti Rana; Mushtaq Ahmed; Abdur Rub; Yusuf Akhter
Journal:  Virulence       Date:  2015-06-24       Impact factor: 5.882

2.  Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.

Authors:  Juan Manuel Belardinelli; Amira Yazidi; Liang Yang; Lucien Fabre; Wei Li; Benoit Jacques; Shiva Kumar Angala; Isabelle Rouiller; Helen I Zgurskaya; Jurgen Sygusch; Mary Jackson
Journal:  ACS Infect Dis       Date:  2016-09-01       Impact factor: 5.084

3.  Genome scale identification, structural analysis, and classification of periplasmic binding proteins from Mycobacterium tuberculosis.

Authors:  Padmani Sandhu; Monika Kumari; Kamal Naini; Yusuf Akhter
Journal:  Curr Genet       Date:  2016-11-17       Impact factor: 3.886

4.  The TbD1 Locus Mediates a Hypoxia-Induced Copper Response in Mycobacterium bovis.

Authors:  Ruoyao Ma; Damien Farrell; Gabriel Gonzalez; John A Browne; Chie Nakajima; Yasuhiko Suzuki; Stephen V Gordon
Journal:  Front Microbiol       Date:  2022-04-14       Impact factor: 6.064

5.  The EXIT Strategy: an Approach for Identifying Bacterial Proteins Exported during Host Infection.

Authors:  E F Perkowski; K E Zulauf; D Weerakoon; J D Hayden; T R Ioerger; D Oreper; S M Gomez; J C Sacchettini; M Braunstein
Journal:  MBio       Date:  2017-04-25       Impact factor: 7.867

Review 6.  MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis.

Authors:  Geoff Melly; Georgiana E Purdy
Journal:  Microorganisms       Date:  2019-03-05

7.  Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps.

Authors:  Hasan Ghajavand; Mansour Kargarpour Kamakoli; Sharareh Khanipour; Shahin Pourazar Dizaji; Morteza Masoumi; Fatemeh Rahimi Jamnani; Abolfazl Fateh; Mehdi Yaseri; Seyed Davar Siadat; Farzam Vaziri
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-02       Impact factor: 4.887

8.  Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.

Authors:  Pamela K Garcia; Thirunavukkarasu Annamalai; Wenjie Wang; Raven S Bell; Duc Le; Paula Martin Pancorbo; Sabah Sikandar; Ahmed Seddek; Xufen Yu; Dianqing Sun; Anne-Catrin Uhlemann; Purushottam B Tiwari; Fenfei Leng; Yuk-Ching Tse-Dinh
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

9.  Virtual screening of a MDR-TB WhiB6 target identified by gene expression profiling.

Authors:  Mahalakshmi Vijayaraj; P A Abhinand; P K Ragunath
Journal:  Bioinformation       Date:  2019-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.